- Thinly traded nano cap MYOS RENS (MYOS +12.2%) heads north on a 6x surge in volume, albeit on turnover of only 79K shares, adding to yesterday's 26% move on 19x higher volume. No particular news accounts for the action, but some other tiny firms have shown similar price action lately, some explained, some not.
- MYOS RENS develops and commercializes biotherapeutic and bionutritional products that improve muscle mass. Its lead product is a nutritional supplement called Fortetropin, a protein/lipid complex consisting of ~250 proteins, ~50 lipids, a range of peptides and other unnamed molecules isolated from egg yolks.
- Recent bullish price action: (PULM -9.1%)(BLPH -7.7%)(OTCQB:IMNP +35%)(JAGX +1.4%)(OTC:BSPM -12.1%)(CYCC +6.3%)(CBIO -6.2%)(OTC:GBIM -5.3%)